Study guide

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity

Key Takeaways Explain This Topic AI

Posterior embryotoxon alone does not diagnose Axenfeld–Rieger syndrome or glaucoma.

Congenital opacity assessment includes corneal size, pressure, lens, iris and posterior potential.

Aniridia affects multiple ocular tissues; baseline foveal hypoplasia may limit acuity.

PAX6/WT1 contiguous deletions require systemic assessment distinct from isolated PAX6 disease.

Last updated: October 2026

A congenital opacity is a whole-eye problem

Congenital corneal opacity can result from developmental dysgenesis, endothelial dysfunction, glaucoma, birth trauma, infection or metabolic disease. Establish whether the opacity is unilateral or bilateral and central or diffuse, then assess corneal size, pressure, iris and lens anatomy and posterior visual potential. Dense opacity can obscure several structures at once. Ultrasound biomicroscopy and posterior ultrasound can help define hidden anatomy, with examination under anaesthesia selected when an adequate assessment is otherwise impossible.

Anterior segment development depends on coordinated surface ectoderm, neuroectoderm and periocular mesenchyme. An abnormal cornea can coexist with iris abnormalities and an abnormal drainage angle. A clear area sufficient for fixation may permit optical and amblyopia treatment without immediate transplantation; a visually obstructing opacity may require earlier intervention. Graft surgery in infants carries substantial rejection, glaucoma and amblyopia burdens, so clearing the cornea alone does not guarantee useful vision.

Peters anomaly and related opacity

Peters anomaly typically has a central corneal opacity with abnormal posterior stroma, Descemet membrane and endothelium, often with iridocorneal adhesions. Some eyes have lens involvement or lenticulocorneal adhesion. Assess the extent and associated glaucoma, microphthalmia or posterior anomalies rather than predicting prognosis from the name alone. The term Peters-plus refers to a syndromic phenotype and should not be used for every severe Peters eye.

Sclerocornea describes scleral-like opacity and vascularisation extending into the cornea, often with poorly defined limbal boundaries. Congenital hereditary endothelial dystrophy causes diffuse corneal oedema and clouding, usually without the pressure-related enlargement of primary congenital glaucoma. Forceps-related Descemet breaks and congenital glaucoma can both cause oedema, but their orientation, size and pressure context differ. Do not assume that a normal pressure recorded late during anaesthesia excludes earlier glaucoma.

Pattern Useful clue Further assessment

Central opacity with iris adhesions Peters-type developmental anomaly Lens, angle, pressure and systemic phenotype

Peripheral scleralisation with indistinct limbus Sclerocornea Corneal extent and associated globe anomalies

Diffuse oedema in normally sized eyes Endothelial disease possible Pressure, family history and genetic assessment

  • Enlarged hazy cornea Pressure-related stretching possible Glaucoma examination and serial growth
  • Axenfeld–Rieger spectrum

A prominent anteriorly displaced Schwalbe line is termed posterior embryotoxon . It can occur in otherwise normal eyes and is not itself a diagnosis of glaucoma. In Axenfeld–Rieger spectrum, additional findings include iris strands to the angle, iris hypoplasia, corectopia or pseudopolycoria. Glaucoma may emerge at different ages, requiring longitudinal assessment rather than only an infant pressure check.

FOXC1 and PITX2 are important associated genes, but the phenotype is genetically heterogeneous. Dental, umbilical, craniofacial and other systemic features guide examination and referral. Avoid assuming every patient shares one gene-specific systemic phenotype. The original FOXC1/PITX2 family study documents variable glaucoma presentation and supports ongoing monitoring. Genetic testing refines counselling but does not replace clinical pressure and nerve assessment.

Aniridia is panocular

PAX6-related aniridia involves partial or severe iris hypoplasia but can also affect foveal development, cornea, lens, angle and optic nerve. Foveal hypoplasia and nystagmus may limit acuity before progressive cataract, glaucoma or keratopathy develops. Residual iris tissue can be present despite the name. Evaluate the entire eye and avoid attributing every visual limitation to glare from the iris defect.

Genetic assessment must consider whether a chromosome 11p13 deletion includes WT1 as well as PAX6, indicating WAGR spectrum and a need for tumour surveillance under an appropriate paediatric programme. Absence of a family history does not exclude this possibility. Not every isolated PAX6 variant carries the same Wilms tumour risk. The current GeneReviews PAX6 chapter distinguishes isolated disease from contiguous deletions and describes suitable testing strategies.

Aniridia-associated keratopathy reflects progressive limbal and surface dysfunction. A corneal graft alone does not correct limbal failure. Cataract or glaucoma surgery can be technically difficult because of tissue abnormalities and surface vulnerability. Plan interventions around the dominant reversible problem, explain the baseline developmental acuity limit and coordinate genetic and systemic care.

Other congenital findings and a clinical decision

A small cornea, large cornea, microphthalmia, coloboma or iris hypoplasia requires assessment of the globe rather than an isolated measurement label. Coloboma may involve iris, retina, choroid or nerve and can coexist with systemic syndromes. Persistent fetal vasculature can accompany lens and anterior abnormalities. An ocular prosthetic or cosmetic concern should not distract from visual-axis, glaucoma and amblyopia risks.

For an infant with bilateral iris hypoplasia and nystagmus, assess foveal structure and the rest of the eye, arrange genetic evaluation and identify systemic surveillance needs. For a unilateral central opacity with a clear peripheral window, determine whether fixation and optical rehabilitation are possible before proposing a graft. A complete answer explains both the developmental diagnosis and the interventions that preserve remaining visual potential.

Sections you finish are checked off in the contents.

  • Up Next
  • IC3D and epithelial or Bowman-layer dystrophies
  • Continue learning